| Dr Hersh Shroff, | |
|
101 Manning Dr, Chapel Hill, NC 27514-4220 | |
| (984) 974-1000 | |
| Not Available |
| Full Name | Dr Hersh Shroff |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 9 Years |
| Location | 101 Manning Dr, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053705640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 289811 (New York) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 2021-01753 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of North Carolina Hospital | Chapel hill, NC | Hospital |
| Rex Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Physicians And Associates | 0648181156 | 1656 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
Even though current guidelines advocate colorectal cancer screenings for those with severe illnesses, they may bring little benefit and may actually pose harm, according to a recent study by Yale School of Medicine researchers published in the Archives of Internal Medicine.
Iroko Pharmaceuticals, LLC today announced that the Phase 3 study evaluating the company's investigational, lower dose submicron indomethacin in post-surgical acute pain met its primary endpoint of demonstrating significant pain relief compared with placebo.
The information will include data on what services doctors used, the average amount they charged Medicare and what they were paid. Doctors have fought such disclosures in the past.
› Verified 9 days ago
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
Even though current guidelines advocate colorectal cancer screenings for those with severe illnesses, they may bring little benefit and may actually pose harm, according to a recent study by Yale School of Medicine researchers published in the Archives of Internal Medicine.
Iroko Pharmaceuticals, LLC today announced that the Phase 3 study evaluating the company's investigational, lower dose submicron indomethacin in post-surgical acute pain met its primary endpoint of demonstrating significant pain relief compared with placebo.
The information will include data on what services doctors used, the average amount they charged Medicare and what they were paid. Doctors have fought such disclosures in the past.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hersh Shroff, 160 Dental Circle Burnett-womack Building Cb #7584, Chapel Hill, NC 27599-0001 Ph: (919) 966-2516 | Dr Hersh Shroff, 101 Manning Dr, Chapel Hill, NC 27514-4220 Ph: (984) 974-1000 |
News Archive
Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.
Even though current guidelines advocate colorectal cancer screenings for those with severe illnesses, they may bring little benefit and may actually pose harm, according to a recent study by Yale School of Medicine researchers published in the Archives of Internal Medicine.
Iroko Pharmaceuticals, LLC today announced that the Phase 3 study evaluating the company's investigational, lower dose submicron indomethacin in post-surgical acute pain met its primary endpoint of demonstrating significant pain relief compared with placebo.
The information will include data on what services doctors used, the average amount they charged Medicare and what they were paid. Doctors have fought such disclosures in the past.
› Verified 9 days ago
Scott Vasher, Gastroenterology Medicare: Medicare Enrolled Practice Location: 130 Mason Farm Rd Fl 4, Chapel Hill, NC 27599 Phone: 919-966-2531 Fax: 919-966-7013 | |
Stephen Andrew Schworer, M.D. PH.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 6013 Farrington Rd, Chapel Hill, NC 27517 Phone: 984-974-2645 | |
Jason Michael Holbrook, Gastroenterology Medicare: Medicare Enrolled Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-1000 | |
Dr. Robert V Kelly, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-4996 Fax: 919-843-5515 | |
Naseem Alavian, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 101 Manning Drive Cb# 7085, Chapel Hill, NC 27599 Phone: 984-974-1904 Fax: 984-974-2216 | |
Dr. Robert William Monteiro, MD Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 315 Meadowmont Village Cir, Chapel Hill, NC 27517 Phone: 919-962-2862 | |
Dr. Amy W Shaheen, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Cb#7110, Chapel Hill, NC 27599 Phone: 919-966-4996 Fax: 919-843-5515 |